메뉴 건너뛰기




Volumn 6, Issue 6, 2006, Pages 401-405

The impact of baseline HR and BP on the tolerability of carvedilol in the elderly: The COLA (Carvedilol Open Label Assessment) II Study

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL;

EID: 33846064170     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200606060-00007     Document Type: Article
Times cited : (6)

References (23)
  • 1
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334 (21): 1349-55
    • (1996) N Engl J Med , vol.334 , Issue.21 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3
  • 2
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353 (9169): 2001-7
    • (1999) Lancet , vol.353 , Issue.9169 , pp. 2001-2007
  • 3
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353 (9146): 9-13
    • (1999) Lancet , vol.353 , Issue.9146 , pp. 9-13
  • 4
    • 0035040375 scopus 로고    scopus 로고
    • Influence of carvedilol on hospitalizations in heart failure: Incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group
    • Fowler MB, Vera-Llonch M, Oster G, et al. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group. J Am Coll Cardiol 2001; 37 (6): 1692-9
    • (2001) J Am Coll Cardiol , vol.37 , Issue.6 , pp. 1692-1699
    • Fowler, M.B.1    Vera-Llonch, M.2    Oster, G.3
  • 5
    • 0034837574 scopus 로고    scopus 로고
    • Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure
    • Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001; 3 (3): 351-7
    • (2001) Eur J Heart Fail , vol.3 , Issue.3 , pp. 351-357
    • Shibata, M.C.1    Flather, M.D.2    Wang, D.3
  • 6
    • 0036290085 scopus 로고    scopus 로고
    • Hospitalization of patients with heart failure: A population-based study
    • Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002; 23 (11): 877-85
    • (2002) Eur Heart J , vol.23 , Issue.11 , pp. 877-885
    • Cowie, M.R.1    Fox, K.F.2    Wood, D.A.3
  • 7
    • 0035820912 scopus 로고    scopus 로고
    • Chronic heart failure in Australian general practice: The Cardiac Awareness Survey and Evaluation (CASE) Study
    • Krum H, Tonkin AM, Currie R, et al. Chronic heart failure in Australian general practice: the Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust 2001; 174 (9): 439-44
    • (2001) Med J Aust , vol.174 , Issue.9 , pp. 439-444
    • Krum, H.1    Tonkin, A.M.2    Currie, R.3
  • 8
    • 1842828981 scopus 로고    scopus 로고
    • Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000
    • Lee DS, Mamdani MM, Austin PC, et al. Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med 2004; 116 (9): 581-9
    • (2004) Am J Med , vol.116 , Issue.9 , pp. 581-589
    • Lee, D.S.1    Mamdani, M.M.2    Austin, P.C.3
  • 9
    • 0037369269 scopus 로고    scopus 로고
    • Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: The BRING-UP experience
    • Maggioni AP, Sinagra G, Opasich C, et al. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 2003; 89 (3): 299-305
    • (2003) Heart , vol.89 , Issue.3 , pp. 299-305
    • Maggioni, A.P.1    Sinagra, G.2    Opasich, C.3
  • 10
    • 2942604718 scopus 로고    scopus 로고
    • A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns
    • Rywik TM, Rywik SL, Korewicki J, et al. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns. Int J Cardiol 2004; 95 (2-3): 177-84
    • (2004) Int J Cardiol , vol.95 , Issue.2-3 , pp. 177-184
    • Rywik, T.M.1    Rywik, S.L.2    Korewicki, J.3
  • 11
    • 0344806945 scopus 로고    scopus 로고
    • The EuroHeart Failure Survey programme: A survey on the quality of care among patients with heart failure in Europe. Part 2: treatment
    • for the Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology
    • Komajda M, Follath F, Swedberg K, et al., for the Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003; 24 (5): 464-74
    • (2003) Eur Heart J , vol.24 , Issue.5 , pp. 464-474
    • Komajda, M.1    Follath, F.2    Swedberg, K.3
  • 12
    • 0033645765 scopus 로고    scopus 로고
    • Baseline predictors of tolerability to carvedilol in patients with chronic heart failure
    • Krum H, Ninio D, MacDonald P. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Heart 2000; 84 (6): 615-9
    • (2000) Heart , vol.84 , Issue.6 , pp. 615-619
    • Krum, H.1    Ninio, D.2    MacDonald, P.3
  • 13
    • 33646474391 scopus 로고    scopus 로고
    • Tolerability of beta-blockers in elderly patients with chronic heart failure: The COLA II study
    • Krum H, Hill J, Fruhwald F, et al. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study. Eur J Heart Fail 2006; 8 (3): 302-7
    • (2006) Eur J Heart Fail , vol.8 , Issue.3 , pp. 302-307
    • Krum, H.1    Hill, J.2    Fruhwald, F.3
  • 14
    • 0035853053 scopus 로고    scopus 로고
    • Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial
    • Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103 (10): 1428-33
    • (2001) Circulation , vol.103 , Issue.10 , pp. 1428-1433
    • Lechat, P.1    Hulot, J.S.2    Escolano, S.3
  • 15
    • 0037370714 scopus 로고    scopus 로고
    • Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: A single centre, observational study
    • Arnold RH, Kotlyar E, Hayward C, et al. Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study. Heart 2003; 89 (3): 293-8
    • (2003) Heart , vol.89 , Issue.3 , pp. 293-298
    • Arnold, R.H.1    Kotlyar, E.2    Hayward, C.3
  • 16
    • 0035978763 scopus 로고    scopus 로고
    • Effect of carvedilol on survival in severe chronic heart failure
    • Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344 (22): 1651-8
    • (2001) N Engl J Med , vol.344 , Issue.22 , pp. 1651-1658
    • Packer, M.1    Coats, A.J.2    Fowler, M.B.3
  • 17
    • 11144358541 scopus 로고    scopus 로고
    • Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study
    • Rouleau JL, Roecker EB, Tendera M, et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 2004; 43 (8): 1423-9
    • (2004) J Am Coll Cardiol , vol.43 , Issue.8 , pp. 1423-1429
    • Rouleau, J.L.1    Roecker, E.B.2    Tendera, M.3
  • 18
    • 27544458100 scopus 로고    scopus 로고
    • Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: Results from the COMET trial
    • Metra M, Torp-Pedersen C, Swedberg K, et al. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 2005; 26 (21): 2259-68
    • (2005) Eur Heart J , vol.26 , Issue.21 , pp. 2259-2268
    • Metra, M.1    Torp-Pedersen, C.2    Swedberg, K.3
  • 19
    • 10644220201 scopus 로고    scopus 로고
    • Beta-blocker therapy in patients with heart failure in the urban setting: Moving beyond clinical trials
    • Estep JD, Mehta SK, Uddin F, et al. Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials. Am Heart J 2004; 148 (6): 958-63
    • (2004) Am Heart J , vol.148 , Issue.6 , pp. 958-963
    • Estep, J.D.1    Mehta, S.K.2    Uddin, F.3
  • 20
    • 0033558688 scopus 로고    scopus 로고
    • Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
    • Macdonald PS, Keogh AM, Aboyoun CL, et al. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure. J Am Coll Cardiol 1999; 33 (4): 924-31
    • (1999) J Am Coll Cardiol , vol.33 , Issue.4 , pp. 924-931
    • Macdonald, P.S.1    Keogh, A.M.2    Aboyoun, C.L.3
  • 21
    • 0036899667 scopus 로고    scopus 로고
    • β blockers in older persons with heart failure: Tolerability and impact on quality of life
    • Baxter AJ, Spensley A, Hildreth A, et al. β blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 2002; 88 (6): 611-4
    • (2002) Heart , vol.88 , Issue.6 , pp. 611-614
    • Baxter, A.J.1    Spensley, A.2    Hildreth, A.3
  • 22
    • 1842731684 scopus 로고    scopus 로고
    • The use of beta-blockers in a tertiary care heart failure clinic: Dosing, tolerance, and outcomes
    • Tandon P, McAlister FA, Tsuyuki RT, et al. The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes. Arch Intern Med 2004; 164 (7): 769-74
    • (2004) Arch Intern Med , vol.164 , Issue.7 , pp. 769-774
    • Tandon, P.1    McAlister, F.A.2    Tsuyuki, R.T.3
  • 23
    • 13544258730 scopus 로고    scopus 로고
    • Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
    • Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26 (3): 215-25
    • (2005) Eur Heart J , vol.26 , Issue.3 , pp. 215-225
    • Flather, M.D.1    Shibata, M.C.2    Coats, A.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.